145 related articles for article (PubMed ID: 36030932)
21. Supplement 2 for the 2004 update of the AAPM Task Group No. 43 Report: Joint recommendations by the AAPM and GEC-ESTRO.
Rivard MJ; Ballester F; Butler WM; DeWerd LA; Ibbott GS; Meigooni AS; Melhus CS; Mitch MG; Nath R; Papagiannis P
Med Phys; 2017 Sep; 44(9):e297-e338. PubMed ID: 28644913
[TBL] [Abstract][Full Text] [Related]
22. GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer.
Kovács G; Pötter R; Loch T; Hammer J; Kolkman-Deurloo IK; de la Rosette JJ; Bertermann H
Radiother Oncol; 2005 Feb; 74(2):137-48. PubMed ID: 15734201
[TBL] [Abstract][Full Text] [Related]
23. Validation of an individualized home-made superficial brachytherapy mold applied for deep nonmelanoma skin cancer.
Jaberi R; Siavashpour Z; Akha NZ; Gholami MH; Jafari F; Biniaz M
Rep Pract Oncol Radiother; 2022; 27(6):1010-1018. PubMed ID: 36632290
[TBL] [Abstract][Full Text] [Related]
24. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study.
Charra-Brunaud C; Harter V; Delannes M; Haie-Meder C; Quetin P; Kerr C; Castelain B; Thomas L; Peiffert D
Radiother Oncol; 2012 Jun; 103(3):305-13. PubMed ID: 22633469
[TBL] [Abstract][Full Text] [Related]
25. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV.
Haie-Meder C; Pötter R; Van Limbergen E; Briot E; De Brabandere M; Dimopoulos J; Dumas I; Hellebust TP; Kirisits C; Lang S; Muschitz S; Nevinson J; Nulens A; Petrow P; Wachter-Gerstner N;
Radiother Oncol; 2005 Mar; 74(3):235-45. PubMed ID: 15763303
[TBL] [Abstract][Full Text] [Related]
26. Equivalence of Gyn GEC-ESTRO guidelines for image guided cervical brachytherapy with EUD-based dose prescription.
Shaw W; Rae WI; Alber ML
Radiat Oncol; 2013 Nov; 8():266. PubMed ID: 24225184
[TBL] [Abstract][Full Text] [Related]
27. Comparison of
Safigholi H; Meigooni AS; Song WY
Med Phys; 2017 Sep; 44(9):4426-4436. PubMed ID: 28494095
[TBL] [Abstract][Full Text] [Related]
28. GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas.
Mazeron JJ; Ardiet JM; Haie-Méder C; Kovács G; Levendag P; Peiffert D; Polo A; Rovirosa A; Strnad V
Radiother Oncol; 2009 May; 91(2):150-6. PubMed ID: 19329209
[TBL] [Abstract][Full Text] [Related]
29. GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: an update.
Hoskin PJ; Colombo A; Henry A; Niehoff P; Paulsen Hellebust T; Siebert FA; Kovacs G
Radiother Oncol; 2013 Jun; 107(3):325-32. PubMed ID: 23773409
[TBL] [Abstract][Full Text] [Related]
30. Dosimetric analysis of 3D image-guided HDR brachytherapy planning for the treatment of cervical cancer: is point A-based dose prescription still valid in image-guided brachytherapy?
Kim H; Beriwal S; Houser C; Huq MS
Med Dosim; 2011; 36(2):166-70. PubMed ID: 20488690
[TBL] [Abstract][Full Text] [Related]
31. Review of clinical brachytherapy uncertainties: analysis guidelines of GEC-ESTRO and the AAPM.
Kirisits C; Rivard MJ; Baltas D; Ballester F; De Brabandere M; van der Laarse R; Niatsetski Y; Papagiannis P; Hellebust TP; Perez-Calatayud J; Tanderup K; Venselaar JL; Siebert FA
Radiother Oncol; 2014 Jan; 110(1):199-212. PubMed ID: 24299968
[TBL] [Abstract][Full Text] [Related]
32. GEC-ESTRO ACROP recommendations on calibration and traceability of HE HDR-PDR photon-emitting brachytherapy sources at the hospital level.
Perez-Calatayud J; Ballester F; Carlsson Tedgren Å; DeWerd LA; Papagiannis P; Rivard MJ; Siebert FA; Vijande J
Radiother Oncol; 2022 Nov; 176():108-117. PubMed ID: 36167195
[TBL] [Abstract][Full Text] [Related]
33. Dose volume histogram constraints in patients with head and neck cancer treated with surgery and adjuvant HDR brachytherapy: A proposal of the head and neck and skin GEC ESTRO Working group.
García-Consuegra A; Gimeno Morales M; Cambeiro M; Tagliaferri L; Kovacs G; Van Limbergen E; Ramos LI; Manuel Arnaiz J; Alcalde J; Lecanda F; Martinez-Monge R
Radiother Oncol; 2021 Jan; 154():128-134. PubMed ID: 32941955
[TBL] [Abstract][Full Text] [Related]
34. Technical aspects of the integration of three-dimensional treatment planning dose parameters (GEC-ESTRO Working Group) into pre-implant planning for LDR gynecological interstitial brachytherapy.
Chi A; Gao M; Nguyen NP; Albuquerque K
Technol Cancer Res Treat; 2009 Jun; 8(3):181-6. PubMed ID: 19445535
[TBL] [Abstract][Full Text] [Related]
35. A dosimetric study of electron beam therapy vs. high-dose-rate mould brachytherapy in adjuvant treatment of non-melanoma skin carcinomas of the head and neck region.
Sen S; Bandyopadhyay A; Pal JK; Ghosh AK; Deb AR
J Contemp Brachytherapy; 2019 Dec; 11(6):547-553. PubMed ID: 31969913
[TBL] [Abstract][Full Text] [Related]
36. [Brachytherapy for head and neck cancers].
Peiffert D; Coche-Dequéant B; Lapeyre M; Renard S
Cancer Radiother; 2018 Jun; 22(4):359-366. PubMed ID: 29858138
[TBL] [Abstract][Full Text] [Related]
37. Recommendations of the Spanish brachytherapy group (GEB) of Spanish Society of Radiation Oncology (SEOR) and the Spanish Society of Medical Physics (SEFM) for high-dose rate (HDR) non melanoma skin cancer brachytherapy.
Rodríguez S; Arenas M; Gutierrez C; Richart J; Perez-Calatayud J; Celada F; Santos M; Rovirosa A
Clin Transl Oncol; 2018 Apr; 20(4):431-442. PubMed ID: 28808925
[TBL] [Abstract][Full Text] [Related]
38. Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature.
Delishaj D; Rembielak A; Manfredi B; Ursino S; Pasqualetti F; Laliscia C; Orlandi F; Morganti R; Fabrini MG; Paiar F
J Contemp Brachytherapy; 2016 Dec; 8(6):533-540. PubMed ID: 28115960
[TBL] [Abstract][Full Text] [Related]
39. High dose rate brachytherapy in nonmelanoma skin cancer-Systematic review.
Krzysztofiak T; Kamińska-Winciorek G; Pilśniak A; Wojcieszek P
Dermatol Ther; 2022 Sep; 35(9):e15675. PubMed ID: 35770511
[TBL] [Abstract][Full Text] [Related]
40. Customized 3D-printed molds for high dose-rate brachytherapy in facial skin cancer: First clinical experience.
Chatzikonstantinou G; Diefenhardt M; Fleischmann M; Meissner M; Scherf C; Trommel M; Ramm U; Rödel C; Tselis N; Licher J
J Dtsch Dermatol Ges; 2023 Jan; 21(1):35-41. PubMed ID: 36657038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
